Elizabeth M. Gonzalez

838 total citations
28 papers, 445 citations indexed

About

Elizabeth M. Gonzalez is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Elizabeth M. Gonzalez has authored 28 papers receiving a total of 445 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Elizabeth M. Gonzalez's work include Sarcoma Diagnosis and Treatment (4 papers), RNA modifications and cancer (3 papers) and Single-cell and spatial transcriptomics (2 papers). Elizabeth M. Gonzalez is often cited by papers focused on Sarcoma Diagnosis and Treatment (4 papers), RNA modifications and cancer (3 papers) and Single-cell and spatial transcriptomics (2 papers). Elizabeth M. Gonzalez collaborates with scholars based in United States, Mexico and Uruguay. Elizabeth M. Gonzalez's co-authors include Kenneth Tan, Louis Tay, Ed Diener, Sushmita Nandy, Arunkumar Arumugam, Rajkumar Lakshmanaswamy, Ramadevi Subramani, Alok Dwivedi, Mahesh Narayan and Conrad A. Naleway and has published in prestigious journals such as Journal of Clinical Oncology, Neurology and Cancer Research.

In The Last Decade

Elizabeth M. Gonzalez

27 papers receiving 437 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Elizabeth M. Gonzalez United States 9 175 74 50 45 41 28 445
Sook‐Young Kim South Korea 14 147 0.8× 29 0.4× 25 0.5× 43 1.0× 40 1.0× 46 629
Pu Ge China 15 216 1.2× 53 0.7× 158 3.2× 53 1.2× 24 0.6× 55 671
Akbar Hedayatizadeh‐Omran Iran 15 103 0.6× 138 1.9× 68 1.4× 25 0.6× 28 0.7× 73 705
Haiyue Zhang China 12 147 0.8× 39 0.5× 26 0.5× 49 1.1× 16 0.4× 55 411
Chun‐Yuan Chen Taiwan 13 247 1.4× 120 1.6× 160 3.2× 79 1.8× 63 1.5× 22 734
Zorin Crăiniceanu Romania 12 106 0.6× 51 0.7× 33 0.7× 27 0.6× 14 0.3× 41 400
Lianlian Zhu China 10 108 0.6× 24 0.3× 34 0.7× 22 0.5× 26 0.6× 16 335
Fatemeh Haghighi Iran 13 107 0.6× 69 0.9× 58 1.2× 36 0.8× 23 0.6× 37 481
Xu He China 10 101 0.6× 36 0.5× 32 0.6× 21 0.5× 15 0.4× 42 384

Countries citing papers authored by Elizabeth M. Gonzalez

Since Specialization
Citations

This map shows the geographic impact of Elizabeth M. Gonzalez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth M. Gonzalez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth M. Gonzalez more than expected).

Fields of papers citing papers by Elizabeth M. Gonzalez

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth M. Gonzalez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth M. Gonzalez. The network helps show where Elizabeth M. Gonzalez may publish in the future.

Co-authorship network of co-authors of Elizabeth M. Gonzalez

This figure shows the co-authorship network connecting the top 25 collaborators of Elizabeth M. Gonzalez. A scholar is included among the top collaborators of Elizabeth M. Gonzalez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elizabeth M. Gonzalez. Elizabeth M. Gonzalez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Colistro, Valentina, et al.. (2024). Exposure to contaminants during active transport in Uruguay, and the effect on health parameters. ISEE Conference Abstracts. 2024(1).
2.
Goodale, Amy, Zohra Kalani, Meghan Wyatt, et al.. (2023). Genome-wide pooled CRISPR screening in neurospheres. Nature Protocols. 18(7). 2014–2031. 5 indexed citations
3.
Gonzalez, Elizabeth M., Atif Ahmed, Katherine Chastain, et al.. (2023). Perinucleolar Compartment (PNC) Prevalence as an Independent Prognostic Factor in Pediatric Ewing Sarcoma: A Multi-Institutional Study. Cancers. 15(8). 2230–2230. 2 indexed citations
4.
Wang, Xin Shelley, et al.. (2023). Symptom burden and functioning status in patients with advanced upper gastrointestinal cancers.. Journal of Clinical Oncology. 41(4_suppl). 311–311. 3 indexed citations
5.
Wang, Yinghong, Malek Shatila, Elizabeth M. Gonzalez, et al.. (2023). Effect of fecal transplantation on patients’ reported outcome after immune checkpoint inhibitor colitis.. Journal of Clinical Oncology. 41(16_suppl). 2645–2645. 8 indexed citations
6.
Durham, Emily L., et al.. (2023). TBCK syndrome: a rare multi-organ neurodegenerative disease. Trends in Molecular Medicine. 29(10). 783–785. 4 indexed citations
7.
Wang, Xin Shelley, Samer A. Srour, Tito R. Mendoza, et al.. (2023). Development and validation of a patient‐reported outcome measure to assess symptom burden after chimeric antigen receptor T‐cell therapy. British Journal of Haematology. 201(4). 738–746. 11 indexed citations
8.
Gonzalez, Elizabeth M., et al.. (2023). Polypyrimidine Tract Binding Protein: A Universal Player in Cancer Development. Current Molecular Medicine. 24(12). 1450–1460. 1 indexed citations
9.
Wang, Yinghong, Malek Shatila, Elizabeth M. Gonzalez, et al.. (2022). S726 Fecal Transplantation Improved Patients’ Reported Outcome After Immune Checkpoint Inhibitor Colitis. The American Journal of Gastroenterology. 117(10S). e508–e509. 1 indexed citations
10.
Ahmed, Atif, Sultan S. Habeebu, Midhat S. Farooqi, et al.. (2021). MYOD1 as a prognostic indicator in rhabdomyosarcoma. Pediatric Blood & Cancer. 68(9). e29085–e29085. 6 indexed citations
11.
Gonzalez, Elizabeth M., Marilyn M. Bui, & Atif Ahmed. (2020). IGF1R immunohistochemistry in Ewing's sarcoma as predictor of response to targeted therapy.. PubMed. 14(4). 17–21. 6 indexed citations
12.
Feldman, David, Anthony J. Garrity, Ryan O’Rourke, et al.. (2020). CloneSifter: enrichment of rare clones from heterogeneous cell populations. BMC Biology. 18(1). 177–177. 16 indexed citations
13.
Ramírez, Carolina & Elizabeth M. Gonzalez. (2018). Methodological proposal for the inter-institutional management of wastes in health care centers in Uruguay. MethodsX. 6. 71–81. 3 indexed citations
14.
Rossi, Fabian, Elizabeth M. Gonzalez, Elisa Rossi, & Nina Tsakadze. (2018). Exploding Head Syndrome as Aura of Migraine with Brainstem Aura: A Case Report. Journal of Oral & Facial Pain and Headache. 32(2). e34–e36. 4 indexed citations
15.
Rossi, Fabian, Elisa Rossi, Arash Rezaei, et al.. (2017). Permanent Cerebellar Degeneration After Acute Hyperthermia with Non-toxic Lithium Levels: a Case Report and Review of Literature. The Cerebellum. 16(5-6). 973–978. 4 indexed citations
16.
Subramani, Ramadevi, Elizabeth M. Gonzalez, Arunkumar Arumugam, et al.. (2016). Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition. Scientific Reports. 6(1). 19819–19819. 136 indexed citations
17.
Lippa, Carol F., et al.. (2014). The Role of Gender Differences in Dementia Caregiver Risk (P3.212). Neurology. 82(10_supplement). 1 indexed citations
19.
Riobó, Pilar & Elizabeth M. Gonzalez. (2008). Café y diabetes mellitus. Medicina Clínica. 131(17). 670–675. 1 indexed citations
20.
Gonzalez, Elizabeth M. & Conrad A. Naleway. (1988). Assessment of the effectiveness of glove use as a barrier technique in the dental operatory. The Journal of the American Dental Association. 117(3). 467–469. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026